The molecular classification of breast cancer, based on the expression of estrogen receptor/progesterone receptor (ER/PR) and epidermal growth factor receptor 2 (HER2), provided different prognostic/predictive implications and therapeutic information [4]. This evidence concerns the gene ERBB2 and breast carcinoma.